memantine has been researched along with Diffuse Myofascial Pain Syndrome in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of memantine on metabolite levels in different areas of the brain and to determine whether changes in metabolite levels correlate with clinical variables in Fibromyalgia (FM) patients." | 9.19 | Changes in metabolites after treatment with memantine in fibromyalgia. A double-blind randomized controlled trial with magnetic resonance spectroscopy with a 6-month follow-up. ( Andrés, E; Fayed, N; Garcia-Campayo, J; Herrera-Mercadal, P; López del Hoyo, Y; Magallon, R; Olivan-Blázquez, B; Pérez-Yus, MC; Puebla-Guedea, M; Viguera, L, 2014) |
| "MEDLINE, EMBASE and CENTRAL databases were searched for comparative trials using memantine, either against placebo or active medications, for chronic pain in adults." | 9.01 | A systematic review and meta-analysis of memantine for the prevention or treatment of chronic pain. ( Kurian, R; Raza, K; Shanthanna, H, 2019) |
| "We have recently reported that memantine has a clinically relevant antimanic and long-lasting mood-stabilizing effect in treatment-resistant bipolar disorders, both as augmenting agent and as monotherapy." | 7.80 | Memantine in the treatment and prophylaxis of bipolar II disorder and comorbid fibromyalgia: a case report. ( DE Chiara, L; Kahn, DA; Koukopoulos, A; Koukopoulos, AE; Serra, G, 2014) |
| "Memantine was administered at doses of 20mg/d after 1 month of titration." | 6.79 | Efficacy of memantine in the treatment of fibromyalgia: A double-blind, randomised, controlled trial with 6-month follow-up. ( Andrés, E; Fayed, N; Garcia-Campayo, J; Herrera-Mercadal, P; López-Del-Hoyo, Y; Magallon, R; Olivan-Blázquez, B; Pérez-Yus, MC; Puebla-Guedea, M; Roca, M, 2014) |
| "Fibromyalgia is a prevalent chronic rheumatic disease of great clinical importance." | 6.78 | Evaluation of the efficacy of memantine in the treatment of fibromyalgia: study protocol for a doubled-blind randomized controlled trial with six-month follow-up. ( Andrés, E; Arcega, R; Garcia-Campayo, J; López-del-Hoyo, Y; Magallon, R; Masluk, B; Olivan-Blázquez, B; Pérez-Yus, MC; Puebla, M; Roca, M, 2013) |
| "To evaluate the efficacy of memantine on metabolite levels in different areas of the brain and to determine whether changes in metabolite levels correlate with clinical variables in Fibromyalgia (FM) patients." | 5.19 | Changes in metabolites after treatment with memantine in fibromyalgia. A double-blind randomized controlled trial with magnetic resonance spectroscopy with a 6-month follow-up. ( Andrés, E; Fayed, N; Garcia-Campayo, J; Herrera-Mercadal, P; López del Hoyo, Y; Magallon, R; Olivan-Blázquez, B; Pérez-Yus, MC; Puebla-Guedea, M; Viguera, L, 2014) |
| "MEDLINE, EMBASE and CENTRAL databases were searched for comparative trials using memantine, either against placebo or active medications, for chronic pain in adults." | 5.01 | A systematic review and meta-analysis of memantine for the prevention or treatment of chronic pain. ( Kurian, R; Raza, K; Shanthanna, H, 2019) |
| "We have recently reported that memantine has a clinically relevant antimanic and long-lasting mood-stabilizing effect in treatment-resistant bipolar disorders, both as augmenting agent and as monotherapy." | 3.80 | Memantine in the treatment and prophylaxis of bipolar II disorder and comorbid fibromyalgia: a case report. ( DE Chiara, L; Kahn, DA; Koukopoulos, A; Koukopoulos, AE; Serra, G, 2014) |
| "Memantine was administered at doses of 20mg/d after 1 month of titration." | 2.79 | Efficacy of memantine in the treatment of fibromyalgia: A double-blind, randomised, controlled trial with 6-month follow-up. ( Andrés, E; Fayed, N; Garcia-Campayo, J; Herrera-Mercadal, P; López-Del-Hoyo, Y; Magallon, R; Olivan-Blázquez, B; Pérez-Yus, MC; Puebla-Guedea, M; Roca, M, 2014) |
| "Fibromyalgia is a prevalent chronic rheumatic disease of great clinical importance." | 2.78 | Evaluation of the efficacy of memantine in the treatment of fibromyalgia: study protocol for a doubled-blind randomized controlled trial with six-month follow-up. ( Andrés, E; Arcega, R; Garcia-Campayo, J; López-del-Hoyo, Y; Magallon, R; Masluk, B; Olivan-Blázquez, B; Pérez-Yus, MC; Puebla, M; Roca, M, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurian, R | 1 |
| Raza, K | 1 |
| Shanthanna, H | 1 |
| Serra, G | 2 |
| DE Chiara, L | 1 |
| Koukopoulos, AE | 1 |
| Koukopoulos, A | 1 |
| Kahn, DA | 1 |
| Olivan-Blázquez, B | 3 |
| Herrera-Mercadal, P | 2 |
| Puebla-Guedea, M | 2 |
| Pérez-Yus, MC | 3 |
| Andrés, E | 3 |
| Fayed, N | 2 |
| López-Del-Hoyo, Y | 2 |
| Magallon, R | 3 |
| Roca, M | 2 |
| Garcia-Campayo, J | 3 |
| López del Hoyo, Y | 1 |
| Viguera, L | 1 |
| Recla, JM | 1 |
| Sarantopoulos, CD | 1 |
| Puebla, M | 1 |
| Masluk, B | 1 |
| Arcega, R | 1 |
1 review available for memantine and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
A systematic review and meta-analysis of memantine for the prevention or treatment of chronic pain.
Topics: Adult; Analgesics; Chronic Pain; Fibromyalgia; Humans; Memantine; Receptors, N-Methyl-D-Aspartate | 2019 |
3 trials available for memantine and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
Efficacy of memantine in the treatment of fibromyalgia: A double-blind, randomised, controlled trial with 6-month follow-up.
Topics: Adult; Cognition Disorders; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Fibromya | 2014 |
Changes in metabolites after treatment with memantine in fibromyalgia. A double-blind randomized controlled trial with magnetic resonance spectroscopy with a 6-month follow-up.
Topics: Adult; Aspartic Acid; Brain; Creatine; Dopamine Agents; Double-Blind Method; Female; Fibromyalgia; F | 2014 |
Evaluation of the efficacy of memantine in the treatment of fibromyalgia: study protocol for a doubled-blind randomized controlled trial with six-month follow-up.
Topics: Brain; Clinical Protocols; Cognition; Double-Blind Method; Drug Administration Schedule; Excitatory | 2013 |
2 other studies available for memantine and Diffuse Myofascial Pain Syndrome
| Article | Year |
|---|---|
Memantine in the treatment and prophylaxis of bipolar II disorder and comorbid fibromyalgia: a case report.
Topics: Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Agents; Female; Fi | 2014 |
Combined use of pregabalin and memantine in fibromyalgia syndrome treatment: a novel analgesic and neuroprotective strategy?
Topics: Analgesics; Chronic Disease; Drug Therapy, Combination; Fibromyalgia; gamma-Aminobutyric Acid; Human | 2009 |